Phase 2 trial to assess investigational COVID-19 vaccine for individuals with cancer - Healio

An investigational COVID-19 vaccine developed by City of Hope induced a robust immune response against SARS-CoV-2, according to results of a phase 1 clinical trial.In addition, researchers observed no significant adverse events.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio An investigational COVID-19 vaccine deve… [+681 chars]

full article...